Transcriptomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504246578

Publication Date:

April 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
The global market for Transcriptomics was estimated to be worth US$ 3775.2 million in 2023 and is forecast to a readjusted size of US$ 7413.6 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcriptomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcriptomics by region & country, by Type, and by Application.
The Transcriptomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptomics.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type:
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transcriptomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Transcriptomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Transcriptomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Transcriptomics Product Introduction
1.2 Global Transcriptomics Market Size Forecast
1.3 Transcriptomics Market Trends & Drivers
1.3.1 Transcriptomics Industry Trends
1.3.2 Transcriptomics Market Drivers & Opportunity
1.3.3 Transcriptomics Market Challenges
1.3.4 Transcriptomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transcriptomics Players Revenue Ranking (2023)
2.2 Global Transcriptomics Revenue by Company (2019-2024)
2.3 Key Companies Transcriptomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Transcriptomics Product Offered
2.5 Key Companies Time to Begin Mass Production of Transcriptomics
2.6 Transcriptomics Market Competitive Analysis
2.6.1 Transcriptomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Transcriptomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR
3.1.2 Microarray
3.1.3 Sequencing
3.2 Global Transcriptomics Sales Value by Type
3.2.1 Global Transcriptomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transcriptomics Sales Value, by Type (2019-2030)
3.2.3 Global Transcriptomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology
4.1.2 Academic Research and Government Institutes
4.1.3 Hospitals and Diagnostic Centers
4.2 Global Transcriptomics Sales Value by Application
4.2.1 Global Transcriptomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transcriptomics Sales Value, by Application (2019-2030)
4.2.3 Global Transcriptomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Transcriptomics Sales Value by Region
5.1.1 Global Transcriptomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transcriptomics Sales Value by Region (2019-2024)
5.1.3 Global Transcriptomics Sales Value by Region (2025-2030)
5.1.4 Global Transcriptomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Transcriptomics Sales Value, 2019-2030
5.2.2 North America Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Transcriptomics Sales Value, 2019-2030
5.3.2 Europe Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Transcriptomics Sales Value, 2019-2030
5.4.2 Asia Pacific Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Transcriptomics Sales Value, 2019-2030
5.5.2 South America Transcriptomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Transcriptomics Sales Value, 2019-2030
5.6.2 Middle East & Africa Transcriptomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transcriptomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transcriptomics Sales Value
6.3 United States
6.3.1 United States Transcriptomics Sales Value, 2019-2030
6.3.2 United States Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transcriptomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transcriptomics Sales Value, 2019-2030
6.4.2 Europe Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transcriptomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transcriptomics Sales Value, 2019-2030
6.5.2 China Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transcriptomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transcriptomics Sales Value, 2019-2030
6.6.2 Japan Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transcriptomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transcriptomics Sales Value, 2019-2030
6.7.2 South Korea Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transcriptomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transcriptomics Sales Value, 2019-2030
6.8.2 Southeast Asia Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transcriptomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transcriptomics Sales Value, 2019-2030
6.9.2 India Transcriptomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transcriptomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Transcriptomics Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Transcriptomics Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Transcriptomics Products, Services and Solutions
7.2.4 Illumina Transcriptomics Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 QIAGEN (Exiqon)
7.3.1 QIAGEN (Exiqon) Profile
7.3.2 QIAGEN (Exiqon) Main Business
7.3.3 QIAGEN (Exiqon) Transcriptomics Products, Services and Solutions
7.3.4 QIAGEN (Exiqon) Transcriptomics Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies Transcriptomics Products, Services and Solutions
7.4.4 Agilent Technologies Transcriptomics Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Transcriptomics Products, Services and Solutions
7.5.4 Roche Transcriptomics Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Transcriptomics Products, Services and Solutions
7.6.4 GE Healthcare Transcriptomics Revenue (US$ Million) & (2019-2024)
7.6.5 GE Healthcare Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Transcriptomics Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Transcriptomics Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Fluidigm
7.8.1 Fluidigm Profile
7.8.2 Fluidigm Main Business
7.8.3 Fluidigm Transcriptomics Products, Services and Solutions
7.8.4 Fluidigm Transcriptomics Revenue (US$ Million) & (2019-2024)
7.8.5 Fluidigm Recent Developments
8 Industry Chain Analysis
8.1 Transcriptomics Industrial Chain
8.2 Transcriptomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transcriptomics Sales Model
8.5.2 Sales Channel
8.5.3 Transcriptomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂